CINCINNATI, Jan. 4 /PRNewswire-FirstCall/ -- Kendle , a leading, global full-service clinical research organization, today announced it has received the 2006 Pfizer Development Operations Strategic Supplier Excellence Award. Kendle provides functional clinical data management services to Pfizer in support of Pfizer’s global drug development efforts. This is the inaugural year for the award program from Pfizer’s Development Operations. It is intended to recognize the Functional Service Provider (FSP) from the existing pool of FSPs supporting Pfizer’s Development Operations that has demonstrated consistent performance in the areas of quality, service delivery and reliability, innovation and business processes, customer service and responsiveness. The winning FSP also must demonstrate excellence in at least one of these areas.
(Logo: http://www.newscom.com/cgi-bin/prnh/20030429/KNDLLOGO )
“It is truly an honor to be recognized in this way by one of our largest customers,” said Candace Kendle, PharmD, Chairman and Chief Executive Officer of Kendle.
Kendle’s Biometrics offerings include clinical data management, biostatistics and scientific programming services. Kendle provides these services for customers worldwide, including many of the world’s largest biopharmaceutical organizations.
About Kendle
Kendle International Inc. is among the world’s leading global clinical research organizations and is the fourth-largest provider of Phase II-IV clinical development services worldwide. We deliver innovative and robust clinical development solutions -- from first-in-human studies through market launch and surveillance -- to help the world’s biopharmaceutical companies maximize product life cycles and grow market share. Our global clinical development business is focused on five regions -- North America, Europe, Asia/Pacific, Latin America and Africa -- to meet customer needs. With the expertise of our 3,000 associates worldwide, Kendle has conducted clinical trials and provided regulatory and pharmacovigilance services in more than 80 countries. The company was named “Best Contract Research Organization” in November 2006 by leading global pharmaceutical publication Scrip World Pharmaceutical News. Additional information and investor kits are available upon request from Kendle, 1200 Carew Tower, 441 Vine Street, Cincinnati, OH 45202 or from the Company’s Web site at www.kendle.com.
Photo: NewsCom: http://www.newscom.com/cgi-bin/prnh/20030429/KNDLLOGOAP Archive: http://photoarchive.ap.orgPRN Photo Desk, photodesk@prnewswire.comKendle International Inc.
CONTACT: Investors, Patty Frank, +1-513-763-1992, or Media, Lori Dorer,+1-513-345-1685, both of Kendle International Inc.
Web site: http://www.kendle.com/
